Please login to the form below
Elliott Levy joins Amgen from BMS
He is appointed senior VP, global development
Dr Elliott Levy has left his role at Bristol-Myers Squibb to join Amgen as senior VO, global development.
Levy was most recently senior VP and head of specialty development at BMS, where he spent 17 years.
During this time he served in a number of senior roles including head of global pharmacovigilance and epidemiology.
“Elliott brings a wealth of development and leadership experience to his new role at Amgen,” said Dr Sean Harper, executive VP of R&D at Amgen.
“His track record shows his success in leading major clinical development programmes, and we're confident that he will help Amgen to serve patients by advancing the large number of potential new medicines in our late-stage pipeline.”
Featured jobs
- Strategic Associate Director Healthcare PR, London
-
Substantiel package
- Publications Director, Medical Communications agency, Home Based...
-
Competitive Salary
- Account Director, Healthcare Communications
-
Salary TBC
- Publications Director, Medical Communications agency, Cambridge
-
Competitive Salary
- Client Partner, Healthcare Brand Communications, London
-
Highly competitive package
- Publications Director, Medical Communications agency, Oxford
-
Competitive Salary
Subscribe to our email news alerts
- 90TEN appoints digital veteran Ged Carroll and Four Health’s Sarah Avent to the senior management team
- Gilead strikes $5.1bn deal to bolster ties with Galapagos
- AbbVie’s Skyrizi gets rapid ‘yes’ from NICE
- Amgen gets block on sales of Repatha rival in Germany
- Precision paediatrics: Treating patients with CAR-T
- Valid Insight: TRAVELLESS, the Virtual Workshop Solution for Pharma
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...
Latest intelligence
- Precision paediatrics: Treating patients with CAR-T
- Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
- What does it mean to be an agile organisation
- We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
- Battling breast cancer with precision medicine (Part 2)
- Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...
Quick links
Infographics
